Regulatory Impact Statements

www.moh.govt.nz/publications/compliance

To help ensure that the business compliance cost implications of regulatory proposals are explicit and consistently and comprehensively considered in developing policy all policy proposals submitted to Cabinet now require a Regulatory Impact Statement (RIS).

Where the policy proposal includes any compliance cost implications for business these are set out in a Business Compliance Cost Statement (BCCS) within the Regulatory Impact Statement. These statements are published on the responsible department's website and linked to the Ministry of Economic Development website.

Ministers and/or Cabinet may wish to review and amend the RIS/BCCS to ensure that they fully reflects the Government's position and are of a high standard. Some changes to the RIS/BCCS accordingly make take place after Cabinet consideration of the Cabinet submission.

Regulatory Impact Statement: Regulation of Psychotherapy and Establishment of the Psychotherapists Board (June 2007)

Regulatory Impact Statement for the Public Health Bill

Regulatory Impact Statement: Human Tissue Review

Changing the Means Testing Regime for Long-Term Residential Care March 2003 (PDF, 61kB) (April 2004)

Changing the Means Testing Regime for Long-Term Residential Care July 2003 (PDF, 85kB) (April 2004)

Proposed Classification of Pseudoephedrine and Ephedrine under the Misuse of Drugs Act 1975 (February 2004)

Ratification of the Framework Convention on Tobacco Control and Consequent Need to Amend the Smoke-Free Environments Regulations (February 2004)

Constituency Arrangements for District Health Board Elections under STV

Development of a Regulatory Framework for the Cultivation of Industrial Hemp in New Zealand (March 2004)

Amending the Regulatory Framework for Designated Prescribers (May 2004)

---

Website feedback
We welcome your feedback on this website.